New diabetes pill outperforms oral semaglutide in weight loss and blood sugar control

TanyaJoy/Getty Images

By Ella Pickover, PA Media

Researchers have suggested a new once-a-day pill offers an “important advancement” in type 2 diabetes care over existing medication.

The medication, orforglipron, was evaluated against the only current tablet version of a GLP-1 receptor agonist – oral semaglutide.